Fulton Murray
Direktor/Vorstandsmitglied bei Dose Therapeutics, Inc.
Profil
Prior to joining Hunt Ventures, Mr. Murray concentrated on private equity investing with regional firms in Australia, South America and Texas.
Mr. Murray also acted as CFO for a small retail chain and spent a year in Monterrey, Mexico evaluating and developing a mini-warehouse strategy for a Dallas-based real estate group.
Mr. Murray holds a BA degree in economics from Stanford University and a MBA degree from The University of Texas at Austin.
Aktive Positionen von Fulton Murray
| Unternehmen | Position | Beginn |
|---|---|---|
Dose Therapeutics, Inc.
 Dose Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Dose Therapeutics, Inc. is an early-stage biotechnology company based in Dallas, TX. Dose Therapeutics focuses on providing solutions for unmet medical needs, with a particular focus on high-risk neuroblastoma, an aggressive and often deadly form of childhood cancer. The company's first development candidate uses the tagging of a protein for degradation to potentially provide a new treatment option for children suffering from neuroblastoma. The company was founded by Steven L. McKnight and Deepak Nijhawan. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Fulton Murray
| Unternehmen | Position | Ende |
|---|---|---|
Covera Ventures
 Covera Ventures Investment ManagersFinance Founded in 1998, Covera Ventures, formerly Hunt Ventures, is a venture capital firm headquartered in Dallas, Texas. The firm spun out from Hunt Consolidated, Inc. in 2009. | Private Equity Investor | 01.01.2006 |
Athenix Corp.
 Athenix Corp. Chemicals: AgriculturalProcess Industries Athenix Corp. develops agricultural herbicide tolerance and insect control chemicals. It provides genes, proteins, processes, traits, and transgenic organisms for multiple sectors including seed, agricultural chemical, specialty chemical, industrial enzymes, and energy. The company was founded by Duck Nicholas Barbara, Carozzi Nadine and Koziel Michael Gene in 2001 and is headquartered in Raleigh, NC. | Direktor/Vorstandsmitglied | - |
Ausbildung von Fulton Murray
| Stanford University | Undergraduate Degree |
| The University of Texas at Austin | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Covera Ventures
Covera Ventures Investment ManagersFinance Founded in 1998, Covera Ventures, formerly Hunt Ventures, is a venture capital firm headquartered in Dallas, Texas. The firm spun out from Hunt Consolidated, Inc. in 2009. | Finance |
Athenix Corp.
Athenix Corp. Chemicals: AgriculturalProcess Industries Athenix Corp. develops agricultural herbicide tolerance and insect control chemicals. It provides genes, proteins, processes, traits, and transgenic organisms for multiple sectors including seed, agricultural chemical, specialty chemical, industrial enzymes, and energy. The company was founded by Duck Nicholas Barbara, Carozzi Nadine and Koziel Michael Gene in 2001 and is headquartered in Raleigh, NC. | Process Industries |
Dose Therapeutics, Inc.
Dose Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Dose Therapeutics, Inc. is an early-stage biotechnology company based in Dallas, TX. Dose Therapeutics focuses on providing solutions for unmet medical needs, with a particular focus on high-risk neuroblastoma, an aggressive and often deadly form of childhood cancer. The company's first development candidate uses the tagging of a protein for degradation to potentially provide a new treatment option for children suffering from neuroblastoma. The company was founded by Steven L. McKnight and Deepak Nijhawan. | Commercial Services |
